Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1985-04-22
1987-01-13
Berch, Mark L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514 49, 514 50, 514269, 514908, 536 23, 544301, 544319, A61K 31515, A61K 31505, C07D23952, C07D23960
Patent
active
046365087
ABSTRACT:
Novel 5-pyrimidinecarboxamides useful for regressing or inhibiting the growth of leukemia and tumors. The compounds have the formula: ##STR1## wherein R.sub.1 is hydrogen or an alkoxy group having from one to four carbon atoms;
REFERENCES:
patent: 3961061 (1976-06-01), Kramer et al.
patent: 4229454 (1980-10-01), Beriger
patent: 4349552 (1982-09-01), Takaya et al.
patent: 4399280 (1983-08-01), de Sousa et al.
Brewer et al., Biochemical Pharmacology, vol. 34, No. 11, pp. 2047-2050, 1985.
Brewer Arthur D.
Minatelli John A.
Berch Mark L.
Gross Marc S.
Kapner Stephen M.
Shedden John A.
Uniroyal Chemical Company, Inc.
LandOfFree
5-pyrimidinecarboxyamides and treatment of leukemia therewith does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 5-pyrimidinecarboxyamides and treatment of leukemia therewith, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 5-pyrimidinecarboxyamides and treatment of leukemia therewith will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2355960